GEHC · GE HealthCare Technologies Inc.
$60.56
-1.43 (-2.31%)
At close · Jul 24
Market Cap
$27.56B
Shares
454.89M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$20.63B
+4.8%
FY2025
Net Income
$2.08B
+4.6%
FY2025
Gross Margin
39.99%
-1.7pp
FY2025
Operating Margin
13.4%
+0.1pp
FY2025
Diluted EPS
$4.55
+4.8%
FY2025
Operating Cash Flow
$1.99B
+1.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|---|
| — | $20.98B | $20.63B | $19.67B | $19.55B | $18.34B | $17.59B | |
| — | $8.21B | $8.25B | $8.21B | $7.92B | $7.18B | $7.17B | |
| — | — | 39.99% | 41.71% | 40.52% | 39.14% | 40.8% | |
| — | $1.26B | $1.26B | $1.31B | $1.21B | $1.03B | $816M | |
| — | $4.3B | $4.23B | $4.27B | $4.28B | $3.63B | $3.56B | |
| — | $296M | $291M | $312M | $362M | $405M | $400M | |
| — | — | $102M | $93M | $37M | $146M | $155M | |
| — | $5.56B | $5.49B | $5.58B | $5.49B | $4.66B | $4.38B | |
| — | $2.65B | $2.76B | $2.63B | $2.44B | $2.52B | $2.8B | |
| — | — | 13.4% | 13.34% | 12.45% | 13.75% | 15.89% | |
| — | $94M | $157M | $55M | $86M | $62M | $123M | |
| — | -$3M | $3M | $8M | $11M | $13M | $27M | |
| — | $12M | $112M | -$22M | $1M | -$31M | $3M | |
| — | $2.58B | $2.77B | $2.58B | $2.36B | $2.51B | $2.88B | |
| — | $604M | $614M | $531M | $743M | $563M | $600M | |
| — | $1.91B | $2.08B | $1.99B | $1.57B | $1.92B | $2.25B | |
| — | — | 10.1% | 10.13% | 8.02% | 10.45% | 12.78% | |
| — | $68M | $70M | $57M | $46M | $51M | $46M | |
| — | — | $2.08B | $1.99B | $1.39B | $1.92B | $2.25B | |
| — | $1.71B | $2.07B | $1.31B | $755M | $1.07B | $2.05B | |
| USD/shares | — | — | $4.56 | $4.37 | $3.05 | $4.22 | $4.95 |
| USD/shares | $0.15* | — | $4.55G | $4.34 | $3.03 | $4.22 | $4.95 |
| shares | — | — | 456M | 456M | 455M | 454M | 454M |
| shares | — | — | 458M | 459M | 458M | 454M | 454M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2021–FY2025: $200M in buybacks, $160M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
1.69×
Medical Devices median 2.14×
EV/EBIT
13.37×
Medical Devices median 21.03×
P/E (TTM)
14.53×
Medical Devices median 27.62×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Imaging Segment | $9,245,000,000 | $8,855,000,000 | $8,944,000,000 | $8,395,000,000 | $9,433,000,000 |
| AVS Segment | $5,354,000,000 | $5,131,000,000 | $5,094,000,000 | $5,012,000,000 | — |
| PCS Segment | $3,086,000,000 | $3,125,000,000 | $3,142,000,000 | $2,916,000,000 | $2,915,000,000 |
| PDx Segment | $2,900,000,000 | $2,508,000,000 | $2,306,000,000 | $1,958,000,000 | $2,018,000,000 |
| Ultrasound Segment | — | — | — | — | $3,172,000,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Other Countries | $9,427,000,000 | $8,919,000,000 | $8,764,000,000 | $8,197,000,000 | $8,015,000,000 |
| United States | $9,168,000,000 | $8,617,000,000 | $8,228,000,000 | $7,819,000,000 | $7,060,000,000 |
| China | $2,031,000,000 | $2,135,000,000 | $2,560,000,000 | $2,325,000,000 | $2,510,000,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Product | $13,661,000,000 | $13,075,000,000 | $13,127,000,000 | $12,044,000,000 | $11,165,000,000 |
| Service | $6,964,000,000 | $6,597,000,000 | $6,425,000,000 | $6,297,000,000 | $6,420,000,000 |
Key facts
CIK
1932393
CUSIP
36266G107
13F (30d)
355 filings
336 filers
Visit website
Investor relations